Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Patients using CVS Caremark can request formulary exceptions or consider alternative coverage options
Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: a randomized controlled trial
Diabetes Care 41 , 258266 (2018)
The confusion starts with the name
Tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and in those with serious hypersensitivity to tirzepatide or its excipients
It is not a medical treatment or cure
US$ 29.50
US$ 29.38
US$ 26.56
US$ 24.88
US$ 27.41
US$ 21.19
US$ 29.05
